Mergers & Acquisitions

Caravel Autism Health Acquired By GTCR

6229 Caravel Autism Health NT

M&A Engagement Overview

Industry Group: Healthcare & Life Sciences
Areas of Focus: Providers, Behavioral

Harris Williams advised Caravel Autism Health, a portfolio company of Frazier Healthcare Partners, on their sale to GTCR. Caravel is a leader in the diagnosis and treatment of young children on the autism spectrum.

GTCR was attracted to Caravel's industry-leading management team, excellent clinical operations and outcomes, robust technological infrastructure and reporting capabilities, and demonstrated ability to drive growth across new and existing clinics. GTCR has extensive experience in the healthcare industry, and they will be an excellent partner to Caravel as the company embarks on their next chapter.

Caravel's proprietary technology platform enables clinicians to track each child's progress in real time and analyze that data on an individual and collective basis to identify trends and insights that can help fine-tune each child's therapy plan and advance autism treatment on the whole. This proprietary software, combined with robust clinical standards, operational support, and career progression opportunities, makes Caravel a platform of choice for clinicians and clients alike.


The ability to deliver high-quality and impactful care, along with the large, unmet need for ABA services and the growing number of children diagnosed with autism spectrum disorder, contribute to the strong investor interest in the behavioral health space.

Contact the Harris Williams Healthcare & Life Sciences Group to learn more about this client engagement.